Gallant

San Diego, United States

Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.

$18.0M raised

Mar 2025

Series B

Top Investors

Alumni VenturesSlow VenturesBling CapitalMaveronDigitalis Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Gallant raised?

Gallant has raised $18.0M in total funding. The most recent round was Series B. The last funding was announced in March 2025.

Who are Gallant's investors?

Gallant's investors include Alumni Ventures, Slow Ventures, Bling Capital, Maveron, Digitalis Ventures.

Where is Gallant headquartered?

Gallant is headquartered in San Diego, United States.

What does Gallant do?

Gallant is advancing investigational stem cell therapies to help give pets more good years, making regenerative care more accessible.

What stage is Gallant at?

Gallant is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 15, 2025.

MLA

"Gallant — Funding & Investors." VCBacked, March 15, 2025, https://www.vcbacked.co/company/gallant. Accessed June 4, 2026.

APA

VCBacked. (2025). Gallant — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/gallant

Wikipedia (cite web)

{{cite web |title=Gallant — Funding & Investors |url=https://www.vcbacked.co/company/gallant |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 15, 2025.